Regulus Therapeutics Inc (RGLS)
2.26
+0.06
(+2.73%)
USD |
NASDAQ |
Apr 23, 16:00
Regulus Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2020 | 0.1787 |
September 30, 2020 | 1.76 |
June 30, 2020 | 1.706 |
March 31, 2020 | 0.9822 |
December 31, 2019 | 0.731 |
September 30, 2019 | -102.28 |
June 30, 2019 | 3.083 |
March 31, 2019 | -2.509 |
December 31, 2018 | -2.831 |
September 30, 2018 | 12.08 |
June 30, 2018 | 1.906 |
March 31, 2018 | 0.8688 |
December 31, 2017 | 0.5639 |
September 30, 2017 | 0.4085 |
June 30, 2017 | 0.9917 |
March 31, 2017 | 0.5117 |
December 31, 2016 | 0.3531 |
September 30, 2016 | 0.2722 |
June 30, 2016 | 0.2237 |
Date | Value |
---|---|
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.1772 |
September 30, 2014 | 0.144 |
June 30, 2014 | 0.1517 |
March 31, 2014 | 0.1452 |
December 31, 2013 | 0.1207 |
September 30, 2013 | 0.1474 |
June 30, 2013 | 0.2959 |
March 31, 2013 | 0.2129 |
December 31, 2012 | 0.1632 |
September 30, 2012 | -0.3337 |
June 30, 2012 | 2.013 |
March 31, 2012 | |
December 31, 2011 | -0.241 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-102.28
Minimum
Sep 2019
3.083
Maximum
Jun 2019
-13.41
Average
0.9822
Median
Mar 2020
Debt to Equity Ratio Benchmarks
ACADIA Pharmaceuticals Inc | 0.00 |
ADMA Biologics Inc | 0.9659 |
FibroGen Inc | -0.3523 |
Protara Therapeutics Inc | -- |
Amylyx Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 30.75M |
Total Liabilities (Quarterly) | 9.563M |
Shareholders Equity (Quarterly) | 21.19M |